Studio multicentrico prospettico sulla cinetica e l’impatto della malattia residua misurabile nei pazienti con Leucemia Mieloide acuta trattati con Venetoclax e Azacitidina

Multicentric, prospective study addressing the kinetics and impact on survival of measurable residual disease in patients with acute Myeloid Leukemia receiving Azacitidine and Venetoclax